SYNANTHIC SUSPENSION 9.06% DIN 02012480
Status: Cancelled Post Market
Holder: SYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC.
Molecule: OXFENDAZOLE
Health Canada record
| Active ingredient(s) | OXFENDAZOLE 90.6 MG |
|---|---|
| Dosage form | Suspension |
| Route | Oral; Refer (See Dosage Form) |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1993 |
| Current status date | 14-Aug-2001 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXFENDAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00592307 | BENZELMIN EQUINE ANTHELMINTIC ORAL PASTE 37.5% | AYERST VETERINARY LABORATORIES | Paste | OXFENDAZOLE 37.5 % | Cancelled Post Market |
| 02231772 | BENZELMIN EQUINE ANTHELMINTIC ORAL SUSPENSION | AYERST VETERINARY LABORATORIES | Suspension | OXFENDAZOLE 9.06 % | Cancelled Post Market |
| 00598895 | BENZELMIN SUSPENSION 90.6MG/ML | SYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC. | Suspension | OXFENDAZOLE 90.6 MG | Cancelled Post Market |
| 01913379 | SYNANTHIC 22.5% SUSPENSION | AYERST VETERINARY LABORATORIES | Suspension | OXFENDAZOLE 22.5 % | Cancelled Post Market |